ADSTILADRIN
Live / Applied — Third extension granted (statement of use) (as of 12 Nov 2025)
What this means for you
Not registered yet, but its 14 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97888081
- Mark type
- Design + words
- Filed
- 14 Apr 2023
- Published for opposition
- 11 Jun 2024
- Attorney of record
- Joyce M. Ferraro
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations to treat cancer and bladder diseases; gene-based pharmaceutical products and preparations to treat cancer and bladder diseases
Owner
- Ferring B.V., Hoofddorp, NL
- Ferring B.V., Hoofddorp, NL
Prosecution history
- 12 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — SOU EXTENSION 3 GRANTED
- 12 Nov 2025 — SOU EXTENSION 3 FILED
- 12 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Mar 2025 — SOU EXTENSION 2 GRANTED
- 10 Mar 2025 — SOU EXTENSION 2 FILED
- 10 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2024 — SOU EXTENSION 1 GRANTED
- 12 Aug 2024 — SOU EXTENSION 1 FILED
- 12 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 01 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED